1. Multinomial phase II cancer trials incorporating response and early progression;Zee;J Biopharm Stats,1999
2. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP-2), but not TIMP-1, inhibit shedding of Tumor Necrosis Factor-α receptors in a human colon adenocarcinoma (Colo 205) cell line;Lombard;Cancer Res,1998
3. Inhibition of HER2 extracellular domain shedding by metalloprotease inhibitors and by Herceptin in breast cancer cells;Albanell;Proc Am Soc Clin Oncol,1999
4. Matrix metalloproteinase inhibitors;Wojtowicz-Praga;Invest New Drugs,1997
5. Expression and prognostic significance of metalloproteinases and their tissues inhibitors in patients with small cell lung cancer;Michael;J Clin Oncol,1999